320 related articles for article (PubMed ID: 17366539)
1. Substrate activation of butyrylcholinesterase and substrate inhibition of acetylcholinesterase by 3,3-dimethylbutyl-N-n-butylcarbamate and 2-trimethylsilyl-ethyl-N-n-butylcarbamate.
Chiou SY; Wu YG; Lin YF; Lin LY; Lin G
J Biochem Mol Toxicol; 2007; 21(1):24-31. PubMed ID: 17366539
[TBL] [Abstract][Full Text] [Related]
2. Activation mechanisms of butyrylcholinesterase by 2,4,6-trinitrotoluene, 3,3-dimethylbutyl-N-n-butylcarbamate, and 2-trimethylsilyl-ethyl-N-n-butylcarbamate.
Chiou SY; Wu YG; Lin G
Appl Biochem Biotechnol; 2008 Sep; 150(3):337-44. PubMed ID: 18563305
[TBL] [Abstract][Full Text] [Related]
3. Ortho effects for inhibition mechanisms of butyrylcholinesterase by o-substituted phenyl N-butyl carbamates and comparison with acetylcholinesterase, cholesterol esterase, and lipase.
Lin G; Lee YR; Liu YC; Wu YG
Chem Res Toxicol; 2005 Jul; 18(7):1124-31. PubMed ID: 16022504
[TBL] [Abstract][Full Text] [Related]
4. Comparison of active sites of butyrylcholinesterase and acetylcholinesterase based on inhibition by geometric isomers of benzene-di-N-substituted carbamates.
Chiou SY; Huang CF; Hwang MT; Lin G
J Biochem Mol Toxicol; 2009; 23(5):303-8. PubMed ID: 19827033
[TBL] [Abstract][Full Text] [Related]
5. Benzene-1,2-, 1,3-, and 1,4-di-N-substituted carbamates as conformationally constrained inhibitors of acetylcholinesterase.
Lin MC; Hwang MT; Chang HG; Lin CS; Lin G
J Biochem Mol Toxicol; 2007; 21(6):348-53. PubMed ID: 17994573
[TBL] [Abstract][Full Text] [Related]
6. Stereo-specific inhibition of acetyl- and butyryl-cholinesterases by enantiomers of cis,cis-decahydro-2-naphthyl-N-n-butylcarbamate.
Lin MC; Yeh SJ; Chen IR; Lin G
J Biochem Mol Toxicol; 2011; 25(5):330-9. PubMed ID: 21630390
[TBL] [Abstract][Full Text] [Related]
7. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
Więckowska A; Bajda M; Guzior N; Malawska B
Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161
[TBL] [Abstract][Full Text] [Related]
8. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
Darvesh S; Darvesh KV; McDonald RS; Mataija D; Walsh R; Mothana S; Lockridge O; Martin E
J Med Chem; 2008 Jul; 51(14):4200-12. PubMed ID: 18570368
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
[TBL] [Abstract][Full Text] [Related]
10. A rate determining step change in the pre-steady state of acetylcholinesterase inhibitions by 1,n-alkane-di-N-butylcarbamates.
Lin G; Tseng HC; Chio AC; Tseng TM; Tsai BY
Bioorg Med Chem Lett; 2005 Feb; 15(4):951-5. PubMed ID: 15686892
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterase: substrate inhibition and substrate activation.
Reiner E; Simeon-Rudolf V
Pflugers Arch; 2000; 440(5 Suppl):R118-20. PubMed ID: 11005636
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of enantiomers of exo-2-norbornyl-N-n-butylcarbamate and endo-2-norbornyl-N-n-butylcarbamate for stereoselective inhibition of acetylcholinesterase.
Chiou SY; Huang CF; Yeh SJ; Chen IR; Lin G
Chirality; 2010 Feb; 22(2):267-74. PubMed ID: 19496158
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates.
Groner E; Ashani Y; Schorer-Apelbaum D; Sterling J; Herzig Y; Weinstock M
Mol Pharmacol; 2007 Jun; 71(6):1610-7. PubMed ID: 17347320
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase.
Rodríguez-Franco MI; Fernández-Bachiller MI; Pérez C; Castro A; Martínez A
Bioorg Med Chem; 2005 Dec; 13(24):6795-802. PubMed ID: 16183292
[TBL] [Abstract][Full Text] [Related]
16. Microcalorimetric study of the inhibition of butyrylcholinesterase by carbamates.
Debord J; Laubarie C; Dantoine T
Anal Biochem; 2008 Feb; 373(2):247-52. PubMed ID: 17950687
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
18. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
[TBL] [Abstract][Full Text] [Related]
20. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B
Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
